Actavis has completed its acquisition of Warner Chilcott in a stock-for-stock transaction valued at approximately $8.5 billion. The combination creates a global specialty pharmaceutical company...

Valeant Pharmaceuticals International has received Health Canada regulatory approval for Jublia (efinaconazole 10% solution), a topical triazole antifungal agent developed for distal lateral...

AAD Call for Nominees

The American Academy of Dermatology (AAD) is accepting nominations for its 2014 elections. Members who are willing to be considered as candidates can submit nominations electronically at...

Allergan (www.allergan.com) has entered into an exclusive licensing agreement with Korean pharmaceutical company Medytox to develop and, if approved,...

Bayer Offers 24/7 Rosacea Support

Bayer Healthcare, maker of Finacea (azelaic acid) Gel, 15%, has updated its Rosacea Concierge (www.rosaceaconcierge.com) program, an online resource...

Modernizing Medicine, the creator of the Electronic Medical Assistant (EMA), a cloud-based specialty-specific electronic medical record (EMR) system, has received $14 million from Summit Partners...